Abraham W T, Young J B, Len A R. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator and mildly symptomatic chronic heart failure [J]. Circulation, 2004.2864.
|
Bertoldi E G, Polanczyk C A, Cunha V. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure:an updated meta-analysis.Does recent evidence change the standard of care [J]. Journal of Cardiac Failure, 2011, (10):860.
|
Dickstein K, Vardas P E, Auricchio A. 2010 Focused Update of ESC Guidelines on device therapy in heart failure:an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy.Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association [J]. European Heart Journal, 2010, (21):2677.
|
Cleland J G, Daubert J C, Erdmann E. The effect of cardiac resynchronization on morbidity and mortality in heart failure [J]. New England Journal of Medicine, 2005, (15):1539.
|
Hunt S A, Abraham W T, Chin M H. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult [J]. Circulation, 2005, (12):e154.
|
Ilan Goldenberg, Arthur J.Moss, W.Jackson Hall. Predictors of response to cardiac resynchronization therapy in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT) [J]. Circulation, 2011.1527.
|
惠玲玲, 张卫泽, 陈永清. 左心室大小和术后收缩压变化与心脏再同步化治疗疗效的关系 [J]. 心脏杂志, 2011(6):741.
|
Natália, Rogério, Loureno. Identification of "super-responders" to cardiac resynchronization therapy:the importance of symptom duration and left ventricular geometry [J]. Europace:European Pacing, Arrhythmias and Cardiac Electrophysiology, 2009.343.
|
巩雪, 宿燕岗, 潘文志. 常用临床和超声指标对心脏再同步化治疗效果的预测价值 [J]. 中华临床医师杂志(电子版), 2011(2):368.doi: 10.3877/cma.j.issn.1674-0785.2011.02.010.
|
Berger R, Shankar A, Fruhwald F. Relationships between cardiac resynchronization therapy and N-terminal probrain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony:an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study [J]. European Heart Journal, 2009, (17):2109.
|
Yu C M, Fung W H, Lin H. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy [J]. American Journal of Cardiology, 2003(6):684.
|
Van Bommel R J, Mollema S A, Borleffs C J. Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy [J]. Journal of the American College of Cardiology, 2011(5):549.
|